Ian Metcalfe

About

Ian Metcalfe is a Venture Partner at Pureos Bioventures. Pureos Bioventures is a venture capital firm based in Switzerland that invests in private drug development companies, with an emphasis on next-generation biological drugs and drug formats. The firm aims to advance innovative treatments for severe diseases. **Ian Metcalfe's Background and Experience:** * Metcalfe joined Pureos Bioventures as a Venture Partner on September 1, 2021. * Prior to joining Pureos, Metcalfe was the CEO of NovaGo Therapeutics in 2020. * He also served as the Chief Operating Officer for Corlieve Therapeutics, which was acquired by uniQure in July 2021. * Metcalfe held positions of increasing responsibility at Roche and Nestlé, including Investor Relations, business development/M&A, Global Product Strategy, and late-stage Pharma Development. * Earlier in his career, he played a key role in Berna Biotech's R&D group and raised funds for the Sicilian-based start-up Etna Biotech. * He is a qualified solicitor and retired as managing partner of the international law firm Wragge & Co in 2014 after eight years in the role. * Before managing Wragge & Co, Metcalfe was a corporate partner at the firm for 14 years, advising public and private companies and private equity houses. * He has over 30 years of experience advising businesses on their growth activities and has corporate governance experience as a legal advisor and board member. * Metcalfe was the Chair of Commonwealth Games Engla